AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
9.62
+0.13 (1.37%)
Mar 9, 2026, 3:30 PM EDT - Market open
AdaptHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 3,245 | 3,261 | 3,200 | 2,971 | 2,465 | Upgrade
|
| Revenue Growth (YoY) | -0.49% | 1.90% | 7.73% | 20.51% | 130.24% | Upgrade
|
| Cost of Revenue | 2,567 | 2,512 | 2,518 | 2,336 | 1,941 | Upgrade
|
| Gross Profit | 677.93 | 749.16 | 681.77 | 634.32 | 524.54 | Upgrade
|
| Selling, General & Admin | 432.72 | 415.86 | 346.16 | 353.31 | 235.84 | Upgrade
|
| Operating Expenses | 473.36 | 460.91 | 403.25 | 418.2 | 298.93 | Upgrade
|
| Operating Income | 204.57 | 288.25 | 278.53 | 216.11 | 225.61 | Upgrade
|
| Interest Expense | -105.75 | -126.67 | -130.3 | -109.41 | -95.2 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.73 | 1.23 | 4.92 | 22.81 | 49.45 | Upgrade
|
| EBT Excluding Unusual Items | 99.54 | 162.81 | 153.14 | 129.5 | 179.86 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -6 | - | Upgrade
|
| Impairment of Goodwill | -128 | -13.08 | -830.79 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 1.9 | Upgrade
|
| Gain (Loss) on Sale of Assets | 32.6 | - | - | 2.4 | - | Upgrade
|
| Legal Settlements | -18.1 | -7.54 | -39.04 | -10.6 | - | Upgrade
|
| Other Unusual Items | -1.2 | -6.17 | -7.1 | -17.4 | 9.2 | Upgrade
|
| Pretax Income | -15.15 | 136.02 | -723.78 | 97.9 | 190.96 | Upgrade
|
| Income Tax Expense | 50.88 | 41.24 | -49 | 24.77 | 32.81 | Upgrade
|
| Earnings From Continuing Operations | -66.04 | 94.78 | -674.78 | 73.13 | 158.15 | Upgrade
|
| Net Income to Company | -66.04 | 94.78 | -674.78 | 73.13 | 158.15 | Upgrade
|
| Minority Interest in Earnings | -4.76 | -4.36 | -4.12 | -3.82 | -1.98 | Upgrade
|
| Net Income | -70.79 | 90.42 | -678.9 | 69.32 | 156.18 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 7.68 | - | 5.87 | 14.38 | Upgrade
|
| Net Income to Common | -70.79 | 82.75 | -678.9 | 63.45 | 141.8 | Upgrade
|
| Net Income Growth | - | - | - | -55.62% | - | Upgrade
|
| Shares Outstanding (Basic) | 135 | 134 | 134 | 134 | 126 | Upgrade
|
| Shares Outstanding (Diluted) | 135 | 136 | 134 | 139 | 133 | Upgrade
|
| Shares Change (YoY) | -0.28% | 0.83% | -3.29% | 4.48% | 153.46% | Upgrade
|
| EPS (Basic) | -0.52 | 0.62 | -5.06 | 0.47 | 1.12 | Upgrade
|
| EPS (Diluted) | -0.52 | 0.61 | -5.31 | 0.33 | 0.67 | Upgrade
|
| EPS Growth | - | - | - | -50.00% | - | Upgrade
|
| Free Cash Flow | 219.38 | 235.78 | 143.2 | -17.56 | 72.37 | Upgrade
|
| Free Cash Flow Per Share | 1.62 | 1.74 | 1.06 | -0.13 | 0.54 | Upgrade
|
| Gross Margin | 20.89% | 22.97% | 21.30% | 21.35% | 21.28% | Upgrade
|
| Operating Margin | 6.30% | 8.84% | 8.70% | 7.27% | 9.15% | Upgrade
|
| Profit Margin | -2.18% | 2.54% | -21.21% | 2.14% | 5.75% | Upgrade
|
| Free Cash Flow Margin | 6.76% | 7.23% | 4.47% | -0.59% | 2.94% | Upgrade
|
| EBITDA | 586.49 | 653.58 | 661.31 | 567.29 | 483.66 | Upgrade
|
| EBITDA Margin | 18.07% | 20.04% | 20.66% | 19.10% | 19.62% | Upgrade
|
| D&A For EBITDA | 381.93 | 365.33 | 382.78 | 351.18 | 258.05 | Upgrade
|
| EBIT | 204.57 | 288.25 | 278.53 | 216.11 | 225.61 | Upgrade
|
| EBIT Margin | 6.30% | 8.84% | 8.70% | 7.27% | 9.15% | Upgrade
|
| Effective Tax Rate | - | 30.32% | - | 25.30% | 17.18% | Upgrade
|
| Advertising Expenses | 21.5 | 22.5 | 22.8 | 19.2 | 18.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.